| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| HILIC NEGATIVE ION MODE | pyruvate | 0.4008 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.6640 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.6733 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.6778 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.6905 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.6996 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7159 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7326 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7329 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7360 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7457 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7485 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7594 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7654 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7704 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7714 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7757 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7765 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7789 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7812 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7844 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7852 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7860 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7865 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7870 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7895 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7917 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7922 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.7976 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8041 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8207 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8216 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8238 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8278 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8361 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8361 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8367 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8374 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8421 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8430 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8465 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8470 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8538 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8545 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8613 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8629 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8638 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8656 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8703 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8735 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8752 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8757 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8782 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8787 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8805 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8816 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8836 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8870 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8908 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8918 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8923 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8953 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8959 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 0.8979 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9031 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9098 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9120 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9121 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9175 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9206 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9232 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9259 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9325 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9334 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9387 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9399 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9417 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9418 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9440 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9456 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9468 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9529 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9533 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9555 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9598 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9603 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9704 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9747 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9770 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9788 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9925 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9950 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 0.9963 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0000 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0050 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0072 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0076 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0092 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0111 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0230 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0259 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0279 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0289 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0303 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0328 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0357 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0471 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0494 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0508 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0538 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0562 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0565 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0612 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0617 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0630 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0688 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0693 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0720 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0762 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0800 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0807 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0828 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0842 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0858 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0873 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0916 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0918 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.0958 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 1.1039 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.1042 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.1094 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.1098 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.1241 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.1268 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 1.1350 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 1.1363 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.1411 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.1449 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.1504 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.1544 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.1549 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.1564 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.1652 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.1691 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 1.1805 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.1827 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.2018 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.2098 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 1.2110 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.2150 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.2197 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 1.2204 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.2211 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.2346 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.2405 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 1.2438 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 1.2518 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.2524 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.2527 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.2529 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 1.2536 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.2650 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.2683 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.2777 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.2863 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.2870 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 1.2877 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.2954 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.3047 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.3165 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.3214 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.3492 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 1.3630 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 1.3670 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.3775 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.3906 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.3960 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | pyruvate | 1.3992 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.4099 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.4477 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.4645 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.4691 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.4897 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.5166 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | pyruvate | 1.5374 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.5422 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | pyruvate | 1.5637 | scaled units | High-Dose | +4HR POST INFUSION |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|